Copyright Reports & Markets. All rights reserved.

Global Anti-Infective Therapy Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Anti-Infective Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Penicillin
    • 1.2.3 Sulphonamides
    • 1.2.4 Aminoglycosides
    • 1.2.5 Fluoroquinolones
    • 1.2.6 Antifungals
    • 1.2.7 Antiprotozoal
    • 1.2.8 Others
  • 1.3 Market by Application
    • 1.3.1 Global Anti-Infective Therapy Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Home User
    • 1.3.3 Hospitals/Clinics
    • 1.3.4 Ambulatory Surgery Centres
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Anti-Infective Therapy Market Perspective (2016-2027)
  • 2.2 Anti-Infective Therapy Growth Trends by Regions
    • 2.2.1 Anti-Infective Therapy Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Anti-Infective Therapy Historic Market Share by Regions (2016-2021)
    • 2.2.3 Anti-Infective Therapy Forecasted Market Size by Regions (2022-2027)
  • 2.3 Anti-Infective Therapy Industry Dynamic
    • 2.3.1 Anti-Infective Therapy Market Trends
    • 2.3.2 Anti-Infective Therapy Market Drivers
    • 2.3.3 Anti-Infective Therapy Market Challenges
    • 2.3.4 Anti-Infective Therapy Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Anti-Infective Therapy Players by Revenue
    • 3.1.1 Global Top Anti-Infective Therapy Players by Revenue (2016-2021)
    • 3.1.2 Global Anti-Infective Therapy Revenue Market Share by Players (2016-2021)
  • 3.2 Global Anti-Infective Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Anti-Infective Therapy Revenue
  • 3.4 Global Anti-Infective Therapy Market Concentration Ratio
    • 3.4.1 Global Anti-Infective Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Anti-Infective Therapy Revenue in 2020
  • 3.5 Anti-Infective Therapy Key Players Head office and Area Served
  • 3.6 Key Players Anti-Infective Therapy Product Solution and Service
  • 3.7 Date of Enter into Anti-Infective Therapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-Infective Therapy Breakdown Data by Type

  • 4.1 Global Anti-Infective Therapy Historic Market Size by Type (2016-2021)
  • 4.2 Global Anti-Infective Therapy Forecasted Market Size by Type (2022-2027)

5 Anti-Infective Therapy Breakdown Data by Application

  • 5.1 Global Anti-Infective Therapy Historic Market Size by Application (2016-2021)
  • 5.2 Global Anti-Infective Therapy Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Anti-Infective Therapy Market Size (2016-2027)
  • 6.2 North America Anti-Infective Therapy Market Size by Type
    • 6.2.1 North America Anti-Infective Therapy Market Size by Type (2016-2021)
    • 6.2.2 North America Anti-Infective Therapy Market Size by Type (2022-2027)
    • 6.2.3 North America Anti-Infective Therapy Market Size by Type (2016-2027)
  • 6.3 North America Anti-Infective Therapy Market Size by Application
    • 6.3.1 North America Anti-Infective Therapy Market Size by Application (2016-2021)
    • 6.3.2 North America Anti-Infective Therapy Market Size by Application (2022-2027)
    • 6.3.3 North America Anti-Infective Therapy Market Size by Application (2016-2027)
  • 6.4 North America Anti-Infective Therapy Market Size by Country
    • 6.4.1 North America Anti-Infective Therapy Market Size by Country (2016-2021)
    • 6.4.2 North America Anti-Infective Therapy Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Anti-Infective Therapy Market Size (2016-2027)
  • 7.2 Europe Anti-Infective Therapy Market Size by Type
    • 7.2.1 Europe Anti-Infective Therapy Market Size by Type (2016-2021)
    • 7.2.2 Europe Anti-Infective Therapy Market Size by Type (2022-2027)
    • 7.2.3 Europe Anti-Infective Therapy Market Size by Type (2016-2027)
  • 7.3 Europe Anti-Infective Therapy Market Size by Application
    • 7.3.1 Europe Anti-Infective Therapy Market Size by Application (2016-2021)
    • 7.3.2 Europe Anti-Infective Therapy Market Size by Application (2022-2027)
    • 7.3.3 Europe Anti-Infective Therapy Market Size by Application (2016-2027)
  • 7.4 Europe Anti-Infective Therapy Market Size by Country
    • 7.4.1 Europe Anti-Infective Therapy Market Size by Country (2016-2021)
    • 7.4.2 Europe Anti-Infective Therapy Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Anti-Infective Therapy Market Size (2016-2027)
  • 8.2 Asia-Pacific Anti-Infective Therapy Market Size by Type
    • 8.2.1 Asia-Pacific Anti-Infective Therapy Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Anti-Infective Therapy Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Anti-Infective Therapy Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Anti-Infective Therapy Market Size by Application
    • 8.3.1 Asia-Pacific Anti-Infective Therapy Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Anti-Infective Therapy Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Anti-Infective Therapy Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Anti-Infective Therapy Market Size by Region
    • 8.4.1 Asia-Pacific Anti-Infective Therapy Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Anti-Infective Therapy Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Anti-Infective Therapy Market Size (2016-2027)
  • 9.2 Latin America Anti-Infective Therapy Market Size by Type
    • 9.2.1 Latin America Anti-Infective Therapy Market Size by Type (2016-2021)
    • 9.2.2 Latin America Anti-Infective Therapy Market Size by Type (2022-2027)
    • 9.2.3 Latin America Anti-Infective Therapy Market Size by Type (2016-2027)
  • 9.3 Latin America Anti-Infective Therapy Market Size by Application
    • 9.3.1 Latin America Anti-Infective Therapy Market Size by Application (2016-2021)
    • 9.3.2 Latin America Anti-Infective Therapy Market Size by Application (2022-2027)
    • 9.3.3 Latin America Anti-Infective Therapy Market Size by Application (2016-2027)
  • 9.4 Latin America Anti-Infective Therapy Market Size by Country
    • 9.4.1 Latin America Anti-Infective Therapy Market Size by Country (2016-2021)
    • 9.4.2 Latin America Anti-Infective Therapy Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Anti-Infective Therapy Market Size (2016-2027)
  • 10.2 Middle East & Africa Anti-Infective Therapy Market Size by Type
    • 10.2.1 Middle East & Africa Anti-Infective Therapy Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Anti-Infective Therapy Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Anti-Infective Therapy Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Anti-Infective Therapy Market Size by Application
    • 10.3.1 Middle East & Africa Anti-Infective Therapy Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Anti-Infective Therapy Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Anti-Infective Therapy Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Anti-Infective Therapy Market Size by Country
    • 10.4.1 Middle East & Africa Anti-Infective Therapy Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Anti-Infective Therapy Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Abbott Laboratories Ltd.
    • 11.1.1 Abbott Laboratories Ltd. Company Details
    • 11.1.2 Abbott Laboratories Ltd. Business Overview
    • 11.1.3 Abbott Laboratories Ltd. Anti-Infective Therapy Introduction
    • 11.1.4 Abbott Laboratories Ltd. Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.1.5 Abbott Laboratories Ltd. Recent Development
  • 11.2 Cipla Ltd.
    • 11.2.1 Cipla Ltd. Company Details
    • 11.2.2 Cipla Ltd. Business Overview
    • 11.2.3 Cipla Ltd. Anti-Infective Therapy Introduction
    • 11.2.4 Cipla Ltd. Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.2.5 Cipla Ltd. Recent Development
  • 11.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))
    • 11.3.1 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Company Details
    • 11.3.2 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Business Overview
    • 11.3.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Introduction
    • 11.3.4 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.3.5 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Recent Development
  • 11.4 Glenmark Pharmaceuticals Limited
    • 11.4.1 Glenmark Pharmaceuticals Limited Company Details
    • 11.4.2 Glenmark Pharmaceuticals Limited Business Overview
    • 11.4.3 Glenmark Pharmaceuticals Limited Anti-Infective Therapy Introduction
    • 11.4.4 Glenmark Pharmaceuticals Limited Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.4.5 Glenmark Pharmaceuticals Limited Recent Development
  • 11.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)
    • 11.5.1 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Company Details
    • 11.5.2 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Business Overview
    • 11.5.3 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Introduction
    • 11.5.4 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.5.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Recent Development
  • 11.6 Lupin Limited
    • 11.6.1 Lupin Limited Company Details
    • 11.6.2 Lupin Limited Business Overview
    • 11.6.3 Lupin Limited Anti-Infective Therapy Introduction
    • 11.6.4 Lupin Limited Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.6.5 Lupin Limited Recent Development
  • 11.7 Panacea Biotec Limited
    • 11.7.1 Panacea Biotec Limited Company Details
    • 11.7.2 Panacea Biotec Limited Business Overview
    • 11.7.3 Panacea Biotec Limited Anti-Infective Therapy Introduction
    • 11.7.4 Panacea Biotec Limited Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.7.5 Panacea Biotec Limited Recent Development
  • 11.8 Novartis AG
    • 11.8.1 Novartis AG Company Details
    • 11.8.2 Novartis AG Business Overview
    • 11.8.3 Novartis AG Anti-Infective Therapy Introduction
    • 11.8.4 Novartis AG Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.8.5 Novartis AG Recent Development
  • 11.9 Pfizer, Inc.
    • 11.9.1 Pfizer, Inc. Company Details
    • 11.9.2 Pfizer, Inc. Business Overview
    • 11.9.3 Pfizer, Inc. Anti-Infective Therapy Introduction
    • 11.9.4 Pfizer, Inc. Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.9.5 Pfizer, Inc. Recent Development
  • 11.10 Ranbaxy Laboratories Limited
    • 11.10.1 Ranbaxy Laboratories Limited Company Details
    • 11.10.2 Ranbaxy Laboratories Limited Business Overview
    • 11.10.3 Ranbaxy Laboratories Limited Anti-Infective Therapy Introduction
    • 11.10.4 Ranbaxy Laboratories Limited Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.10.5 Ranbaxy Laboratories Limited Recent Development
  • 11.11 Sun Pharmaceutical Industries Limited
    • 11.11.1 Sun Pharmaceutical Industries Limited Company Details
    • 11.11.2 Sun Pharmaceutical Industries Limited Business Overview
    • 11.11.3 Sun Pharmaceutical Industries Limited Anti-Infective Therapy Introduction
    • 11.11.4 Sun Pharmaceutical Industries Limited Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.11.5 Sun Pharmaceutical Industries Limited Recent Development
  • 11.12 AstraZeneca plc
    • 11.12.1 AstraZeneca plc Company Details
    • 11.12.2 AstraZeneca plc Business Overview
    • 11.12.3 AstraZeneca plc Anti-Infective Therapy Introduction
    • 11.12.4 AstraZeneca plc Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.12.5 AstraZeneca plc Recent Development
  • 11.13 Johnson & Johnson
    • 11.13.1 Johnson & Johnson Company Details
    • 11.13.2 Johnson & Johnson Business Overview
    • 11.13.3 Johnson & Johnson Anti-Infective Therapy Introduction
    • 11.13.4 Johnson & Johnson Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.13.5 Johnson & Johnson Recent Development
  • 11.14 WOCKHARDT
    • 11.14.1 WOCKHARDT Company Details
    • 11.14.2 WOCKHARDT Business Overview
    • 11.14.3 WOCKHARDT Anti-Infective Therapy Introduction
    • 11.14.4 WOCKHARDT Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.14.5 WOCKHARDT Recent Development
  • 11.15 F. Hoffmann-La Roche Ltd
    • 11.15.1 F. Hoffmann-La Roche Ltd Company Details
    • 11.15.2 F. Hoffmann-La Roche Ltd Business Overview
    • 11.15.3 F. Hoffmann-La Roche Ltd Anti-Infective Therapy Introduction
    • 11.15.4 F. Hoffmann-La Roche Ltd Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.15.5 F. Hoffmann-La Roche Ltd Recent Development
  • 11.16 Sanofi
    • 11.16.1 Sanofi Company Details
    • 11.16.2 Sanofi Business Overview
    • 11.16.3 Sanofi Anti-Infective Therapy Introduction
    • 11.16.4 Sanofi Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.16.5 Sanofi Recent Development
  • 11.17 Merck
    • 11.17.1 Merck Company Details
    • 11.17.2 Merck Business Overview
    • 11.17.3 Merck Anti-Infective Therapy Introduction
    • 11.17.4 Merck Revenue in Anti-Infective Therapy Business (2016-2021)
    • 11.17.5 Merck Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Anti-Infective Therapy Scope and Market Size
    Anti-Infective Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Infective Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Penicillin
    Sulphonamides
    Aminoglycosides
    Fluoroquinolones
    Antifungals
    Antiprotozoal
    Others

    Segment by Application
    Home User
    Hospitals/Clinics
    Ambulatory Surgery Centres
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Abbott Laboratories Ltd.
    Cipla Ltd.
    Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))
    Glenmark Pharmaceuticals Limited
    GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)
    Lupin Limited
    Panacea Biotec Limited
    Novartis AG
    Pfizer, Inc.
    Ranbaxy Laboratories Limited
    Sun Pharmaceutical Industries Limited
    AstraZeneca plc
    Johnson & Johnson
    WOCKHARDT
    F. Hoffmann-La Roche Ltd
    Sanofi
    Merck

    Buy now